Barclays PLC Cytosorbents Corp Transaction History

Barclays PLC

  • $288 Billion
  • Q1 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023
BUY
$1.86 - $4.03 $10,373 - $22,475
5,577 New
5,577 $10,000
Q2 2022

Aug 12, 2022
SELL
$1.76 - $3.22 $11,492 - $21,026
-6,530 Reduced 97.55%
164 $0
Q1 2022

May 16, 2022
SELL
$2.88 - $4.23 $124,868 - $183,400
-43,357 Reduced 86.63%
6,694 $22,000
Q4 2021

Feb 14, 2022
BUY
$4.05 - $8.11 $133,184 - $266,697
32,885 Added 191.57%
50,051 $210,000
Q3 2021

Nov 09, 2021
BUY
$7.0 - $9.71 $78,547 - $108,955
11,221 Added 188.75%
17,166 $140,000
Q2 2021

Aug 13, 2021
SELL
$7.55 - $9.42 $214,412 - $267,518
-28,399 Reduced 82.69%
5,945 $45,000
Q1 2021

May 13, 2021
BUY
$8.23 - $11.48 $173,521 - $242,044
21,084 Added 159.0%
34,344 $299,000
Q4 2020

Feb 11, 2021
SELL
$7.65 - $8.98 $42,381 - $49,749
-5,540 Reduced 29.47%
13,260 $105,000
Q3 2020

Nov 12, 2020
SELL
$7.37 - $11.54 $73 - $115
-10 Reduced 0.05%
18,800 $150,000
Q2 2020

Aug 12, 2020
BUY
$6.28 - $10.59 $54,623 - $92,111
8,698 Added 86.02%
18,810 $185,000
Q1 2020

May 13, 2020
SELL
$3.77 - $7.73 $77,318 - $158,534
-20,509 Reduced 66.98%
10,112 $77,000
Q4 2019

Feb 10, 2020
BUY
$3.61 - $5.22 $55,785 - $80,664
15,453 Added 101.88%
30,621 $118,000
Q3 2019

Nov 14, 2019
SELL
$4.33 - $7.63 $19,796 - $34,884
-4,572 Reduced 23.16%
15,168 $76,000
Q2 2019

Aug 14, 2019
SELL
$5.92 - $7.78 $7,488 - $9,841
-1,265 Reduced 6.02%
19,740 $130,000
Q1 2019

May 15, 2019
BUY
$6.82 - $8.56 $50,570 - $63,472
7,415 Added 54.56%
21,005 $159,000
Q4 2018

Feb 14, 2019
BUY
$7.05 - $12.64 $10,694 - $19,174
1,517 Added 12.57%
13,590 $109,000
Q3 2018

Nov 14, 2018
BUY
$10.95 - $14.8 $106,959 - $144,566
9,768 Added 423.77%
12,073 $155,000
Q2 2018

Aug 14, 2018
SELL
$6.9 - $12.35 $35,997 - $64,429
-5,217 Reduced 69.36%
2,305 $27,000
Q1 2018

May 15, 2018
SELL
$6.55 - $8.2 $168,138 - $210,493
-25,670 Reduced 77.34%
7,522 $53,000
Q4 2017

Feb 14, 2018
BUY
$5.9 - $7.05 $195,832 - $234,003
33,192
33,192 $216,000

Others Institutions Holding CTSO

# of Institutions
53
Shares Held
17.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cytosorbents Corp

CTSO Quotes by TradingView
  • Ticker CTSO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 43,577,400
  • Market Cap $39.7M
  • Description
  • Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...
More about CTSO
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email